Cordlife Group (SGX:P8A), a cord blood banking company, has been directed by the Ministry of Health (MOH) to comply with new operational restrictions starting Sept. 15, according to a Friday filing on the Singapore Exchange.
Under the Third Notice issued by the MOH, the company must limit its cord blood collection, testing, processing, and storage to 30 units per month until Jan. 13, 2025.
The company has confirmed it will adhere to these restrictions, which will impact its operations and are expected to negatively affect its financial performance for the fiscal year ending Dec. 31, 2024.